At 24, Alexis Klimpl was diagnosed with stage 2 breast cancer on July 19,2025. Now 25, she's navigating menopause, recovery, and hope. Here’s her inspiring survivor story.
A new hope as novel research spotlights the role of PHGDH, an enzyme that steers immune cells away from an immunosuppressive state and toward tumor-fighting behavior in breast cancer tissue.